openPR Logo
Press release

Pompe Disease Treatment Market reached US$ 1.39 billion in 2024 and is expected to reach US$ 2.11 billion by 2033 - Sanofi, Amicus Therapeutics, AskBio Inc.

03-24-2025 01:29 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Pompe Disease Treatment Market

Pompe Disease Treatment Market

The Global Pompe disease treatment market reached US$ 1.39 billion in 2024 and is expected to reach US$ 2.11 billion by 2033, growing at a CAGR of 4.8% during the forecast period of 2025-2033.

Pompe Disease Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/pompe-disease-treatment-market?rk

Pompe Disease Treatment involves enzyme replacement therapy (ERT) and supportive care to manage this rare genetic disorder caused by glycogen buildup in muscles. Without treatment, Pompe disease leads to progressive muscle weakness and respiratory failure. Advances in gene therapy and novel drug formulations are expanding treatment options. Increased awareness and newborn screening programs are improving early diagnosis and outcomes.

List of the Key Players in the Pompe Disease Treatment Market:

Sanofi, Amicus Therapeutics, AskBio Inc., Beijing GeneCradle Technology Co., Ltd., Aro Biotherapeutics Company.

Industry Development:

In February 2025, Aro Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for ABX1100, a novel therapy currently being evaluated in a Phase 1 study for patients with late-onset Pompe disease (LOPD).

For Direct Purchase: https://www.datamintelligence.com/buy-now-page?report=pompe-disease-treatment-market?rk

Growth Forecast Projected:

The Global Pompe Disease Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Pompe Disease Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/pompe-disease-treatment-market?rk

Segment Covered in the Pompe Disease Treatment Market:

By Disease Type: Infantile-Onset Pompe Disease, Classic Infantile Form, Non-Classic Infantile Form, Late-Onset Pompe Disease.

By Drug: Alglucosidase Alfa, Avalglucosidase Alfa, Cipaglucosidase Alfa, Miglustat.

By Route of Administration: Parenteral, Oral, By Age Group, Pediatrics, Adults.

Regional Analysis for Pompe Disease Treatment Market:

The regional analysis of the Pompe Disease Treatment Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pompe-disease-treatment-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Pompe Disease Treatment market?

➠ Who are the leading manufacturers in the global Pompe Disease Treatment industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Pompe Disease Treatment industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Pompe Disease Treatment market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/pompe-disease-treatment-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pompe Disease Treatment Market reached US$ 1.39 billion in 2024 and is expected to reach US$ 2.11 billion by 2033 - Sanofi, Amicus Therapeutics, AskBio Inc. here

News-ID: 3933402 • Views:

More Releases from DataM Intelligence 4market Research LLP

Insulated Concrete Form Market Growth Drivers and Distribution Channels Forecast to 2024-2031 - Leading Companies are BASF SE, Beco Products Ltd, Durisol UK.
Insulated Concrete Form Market Growth Drivers and Distribution Channels Forecast …
The Global Insulated Concrete Form Market reached US$ 0.9 billion in 2022 and is expected to reach US$ 1.8 billion by 2031, growing with a CAGR of 5.8% during the forecast period 2024-2031. Insulated Concrete Form Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay
System Integrator Market to Reach USD 37.1 Billion by 2031 | Capgemini, Cisco, Fujitsu Leading the Way
System Integrator Market to Reach USD 37.1 Billion by 2031 | Capgemini, Cisco, F …
Global System Integrator Market reached US$ 26.1 billion in 2022 and is expected to reach US$ 37.1 billion by 2031, growing with a CAGR of 4.8% during the forecast period 2024-2031. System Integrator Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the
Recycled Plastic Market to Hit USD 95.5 Billion by 2031 | Veolia, Shell, Waste Connections Drive Growth.
Recycled Plastic Market to Hit USD 95.5 Billion by 2031 | Veolia, Shell, Waste C …
The Global Recycled Plastic Market reached US$ 48.6 billion in 2022 and is expected to reach US$ 95.5 billion by 2031, growing with a CAGR of 8.9% during the forecast period 2024-2031. Recycled Plastic Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of
Customer Intelligence Platform Market to Hit USD 14.8 Billion by 2031 | Google, SAP & Microsoft at the Forefront
Customer Intelligence Platform Market to Hit USD 14.8 Billion by 2031 | Google, …
The Global Customer Intelligence Platform Market reached US$ 2.0 Billion in 2022 and is expected to reach US$ 14.8 Billion by 2031, growing with a CAGR of 29.1% during the forecast period 2024-2031. Customer Intelligence Platform Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay

All 5 Releases


More Releases for Pompe

Pompe Disease Therapeutic Market - Increasing prevalence of pompe disease in man …
Pompe Disease Therapeutic Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Pompe Disease Therapeutic Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis. This comprehensive
Pompe Disease Drug Market Epidemiology 2030| Delveinsight
DelveInsight's Pompe Disease Market Insights, Epidemiology, and Market Forecast 2030 report delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Pompe Disease market report provides current treatment practices, emerging drugs, Pompe Disease market share of the individual therapies, current and forecasted Pompe Disease market Size
Pompe Disease Therapeutic Market - Attractive Growth Opportunities 2017 - 2025
Manufacturers are focusing on finding new solutions by expanding their pipeline to cater the demand for pompe disease therapeutics market. For instance, in September, 2017, Avrobio Inc. expanded their products pipeline with gene therapy to treat pompe disease by utilizing a proprietary lysosomal targeting sequence to deliver high levels of enzyme to lysosomes. Furthermore, in October 2017, Amicus Therapeutics received orphan drug designation to ATB200/AT2221 from the U.S. FDA for
Pompe Disease Market Growth Analysis up to 2024
Pompe disease is a rare, progressive, autosomal recessively inherited metabolic disorder, and is often a fatal muscular disease that affects one of the lysosomal enzymes. Pompe disease can also be called as a glycogen storage disease or acid alpha-glycosidase deficiency or GAA deficiency. It mainly occurs due to accumulation of glycogen in some tissues and organs, particularly muscles, leading to abnormal functioning. The inability of breaking the lysosomal glycogen lies
Pompe Disease Market Intelligence with Competitive Landscape 2024
Pompe disease is a rare, progressive, autosomal recessively inherited metabolic disorder, and is often a fatal muscular disease that affects one of the lysosomal enzymes. Pompe disease can also be called as a glycogen storage disease or acid alpha-glycosidase deficiency or GAA deficiency. It mainly occurs due to accumulation of glycogen in some tissues and organs, particularly muscles, leading to abnormal functioning. The inability of breaking the lysosomal glycogen lies
Pompe Disease Market Size – Industry Share Report 2024
Pompe disease is a rare, progressive, autosomal recessively inherited metabolic disorder, and is often a fatal muscular disease that affects one of the lysosomal enzymes. Pompe disease can also be called as a glycogen storage disease or acid alpha-glycosidase deficiency or GAA deficiency. It mainly occurs due to accumulation of glycogen in some tissues and organs, particularly muscles, leading to abnormal functioning. The inability of breaking the lysosomal glycogen lies